Trademark: 97371557
Word
VCTX210
Status
Pending
Status Code
730
Status Date
Monday, August 28, 2023
Serial Number
97371557
Mark Type
4000
Filing Date
Wednesday, April 20, 2022
Published for Opposition
Tuesday, March 21, 2023
Trademark Owner History
CRISPR Therapeutics AG - Owner At Publication
Classifications
5 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
VCTX 210
Trademark Events
Aug 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 28, 2023
Sou Extension 1 Granted
Aug 28, 2023
Sou Extension 1 Filed
Aug 28, 2023
Sou Teas Extension Received
Jul 3, 2023
Assigned To Examiner
May 16, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 21, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 21, 2023
Published For Opposition
Mar 1, 2023
Notification Of Notice Of Publication E-Mailed
Feb 10, 2023
Approved For Pub - Principal Register
Feb 7, 2023
Assigned To Examiner
Apr 26, 2022
New Application Office Supplied Data Entered
Apr 23, 2022
New Application Entered
SOURCE INFUSIONS
GUDUZHE
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov